7.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.00
Aprire:
$6.88
Volume 24 ore:
172.21K
Relative Volume:
0.49
Capitalizzazione di mercato:
$364.92M
Reddito:
-
Utile/perdita netta:
$-19.90M
Rapporto P/E:
-13.32
EPS:
-0.53
Flusso di cassa netto:
$-19.80M
1 W Prestazione:
+2.62%
1M Prestazione:
+2.77%
6M Prestazione:
+70.12%
1 anno Prestazione:
+61.56%
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
Nome
Diamedica Therapeutics Inc
Settore
Industria
Telefono
(763) 496-5454
Indirizzo
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Confronta DMAC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
DMAC
Diamedica Therapeutics Inc
|
7.06 | 361.82M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-30 | Iniziato | TD Cowen | Buy |
| 2024-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-24 | Ripresa | Craig Hallum | Buy |
| 2023-06-22 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-04-09 | Iniziato | Oppenheimer | Outperform |
| 2021-02-17 | Iniziato | ROTH Capital | Buy |
| 2020-10-30 | Iniziato | Guggenheim | Buy |
| 2020-07-08 | Iniziato | Maxim Group | Buy |
| 2019-04-30 | Iniziato | Dougherty & Company | Buy |
| 2019-03-05 | Iniziato | Lake Street | Buy |
Mostra tutto
Diamedica Therapeutics Inc Borsa (DMAC) Ultime notizie
Developing predictive dashboards with DiaMedica Therapeutics Inc. dataQuarterly Profit Summary & Detailed Earnings Play Strategies - newser.com
Is DiaMedica Therapeutics Inc. stock cheap at current valuation2025 Year in Review & Fast Moving Stock Trade Plans - newser.com
Will DiaMedica Therapeutics Inc. stock attract ESG investorsMarket Volume Summary & Low Risk Entry Point Guides - newser.com
How institutional buying supports DiaMedica Therapeutics Inc. stockGap Up & Community Consensus Stock Picks - newser.com
Will DiaMedica Therapeutics Inc. stock reach Wall Street targetsQuarterly Profit Report & Daily Market Momentum Tracking - newser.com
Will DiaMedica Therapeutics Inc. stock outperform tech sector in 2025IPO Watch & Long-Term Capital Growth Strategies - newser.com
Smart tools for monitoring DiaMedica Therapeutics Inc.’s price actionCEO Change & Weekly Market Pulse Updates - newser.com
Can DiaMedica Therapeutics Inc. stock double in next 5 years2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Short interest data insights for DiaMedica Therapeutics Inc.Oil Prices & Community Supported Trade Ideas - newser.com
Can DiaMedica Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-11-01 02:03:37 - newser.com
What momentum shifts mean for DiaMedica Therapeutics Inc.2025 Winners & Losers & Safe Swing Trade Setup Alerts - newser.com
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Coverage Initiated at TD Cowen - MarketBeat
Why Wall Street Experts Believe This Biotech Stock Represents a Major Opportunity - Barchart.com
Sector ETF performance correlation with DiaMedica Therapeutics Inc.Trade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-10-31 05:34:37 - newser.com
Why DiaMedica Therapeutics Inc. stock remains on watchlistsQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
Has DiaMedica Therapeutics Inc. formed a bullish divergenceQuarterly Portfolio Summary & Fast Moving Stock Watchlists - newser.com
Can DiaMedica Therapeutics Inc. stock hit analyst price targetsMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Live market analysis of DiaMedica Therapeutics Inc.Quarterly Trade Summary & Risk Managed Investment Signals - newser.com
What valuation multiples suggest for DiaMedica Therapeutics Inc. stockJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Visual analytics tools that track DiaMedica Therapeutics Inc. performanceJuly 2025 Reactions & Safe Capital Growth Tips - newser.com
Order flow analysis tools used on DiaMedica Therapeutics Inc.2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com
DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen By Investing.com - Investing.com South Africa
DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen - Investing.com
Using flow based indicators on DiaMedica Therapeutics Inc.2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Using economic indicators to assess DiaMedica Therapeutics Inc. potentialJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-10-29 21:21:04 - newser.com
Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):